You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 6, 2025

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Xiaoxian Liu1, Yifan Zhu1, Caoxin Li1
1College of Engineering and Applied Sciences, Nanjing University, Jiangsu, 210093, China; Key Laboratory of Intelligent Optical Sensing and Integration of the Ministry of Education, Nanjing University, Jiangsu, 210009, China.
A new droplet microfluidic method offers ultrasensitive, quantitative analysis of human epidermal growth factor receptor 2 (HER2) protein on single cells. This approach improves accuracy and reduces variability for better breast cancer diagnosis and treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: